Newsroom

STUART, Fla.--(BUSINESS WIRE)--Stuart Therapeutics, Inc. (“Stuart”), a late-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of Dave LeCause as senior commercial advisor. LeCause will lead the company's commercial strategy as Stuart advances its lead therapeutic candidate, ST-100 for dry eye disease. ST-100 is expected to begin Phase 3b clinical trials in the first quarter of 2027. LeCause joins Stu...

LINCOLN, Neb.--(BUSINESS WIRE)--Nestimate, the innovative investment due diligence platform, has announced that its Target-Date Fund IQ Analysis tool is now available through PGIM, giving retirement plan advisors access to an objective framework for evaluating target-date funds and lifetime income solutions. Through this collaboration, retirement plan advisors can reach out to their PGIM Defined Contribution (DC) Solutions representative to run Nestimate’s reporting, enabling them to work direc...

NEW YORK--(BUSINESS WIRE)--Better Mortgage (NASDAQ: BETR) and Coinbase (NASDAQ: COIN) today announced general availability for Better’s token-backed, conforming mortgage product. These first-of-its-kind mortgages will be originated and serviced by Better, powered by Coinbase, and designed in accordance with guidelines from Fannie Mae, making the first lien a standard, conforming mortgage.As part of this offering, if approved for a loan by Better, Coinbase One members will be eligible for a rebat...

SAN FRANCISCO--(BUSINESS WIRE)--ThisIsMenopause survey: 82% of women mistook first perimenopause symptoms for stress or aging. New community launched to close that gap....

ATLANTA--(BUSINESS WIRE)--QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced an amendment to the surface lease at its Oklahoma data center, extending the company’s potential tenure at the site through January 31, 2044. The amendment replaces the single five-year renewal option in the original lease with three consecutive five-year renewal options, each exercisable at the company’s election upon written notice 60 days’ prior to th...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced details for a dedicated Program Overview webinar for XP-8121, the Company’s Phase 3-ready, once-weekly subcutaneous levothyroxine injection in development for the treatment of hypothyroidism. The XP-8121 webinar will take place on Wednesday, Septemb...

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that its senior leadership team will be participating in a fireside chat at the 2026 Jefferies Global Industrials Conference on Wednesday, September 9 at 9:30 a.m. ET. A live webcast link and archived replay will be available in the “Events” area on the Investor Relations page of APi’s website at APi Group Investor Relations - Events. Interested parties should check the Company’s web...

LONDON--(BUSINESS WIRE)--  Please be advised that the following issue has redeemed early: ISIN: XS2897405036 Issuer: European Bank For Reconstruction And Development Call Date: 10/09/2026 Amount Redeeming: ZAR 1,000,000,000 Call Price: 37.876%...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 25.08.2026 FEUZ IE00B8X9NY41 1,647,274.00 EUR 108,710,167.12   65.994  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 25.08.2026 FEUD IE00BF2FL590 345,463.00 EUR 19,882,686.84 57.554  ...